A review, recently published in the Journal of Cannabis Research , focuses on the use of cannabidiol (CBD) for therapeutic purposes. Also examines the clinical evidence supporting its effectiveness in various conditions. Currently, only one CBD product called Epidiolex is approved to treat seizures in specific syndromes. This review highlights the areas where purified CBD has the most clinical evidence for its potential benefits. These include: Anxiety (positive data from 24 different studies) Psychosis and schizophrenia (positive data from 9), PTSD (positive data from 6), and Substance abuse (positive data from 5 ). Since the 1970s, researchers have studied how cannabidiol (CBD) affects anxiety and stress in both healthy volunteers and patient groups. Acute dosages of CBD have been shown in investigations involving healthy volunteers to lessen the anxiety that tetrahydrocannabinol (THC) administration causes. CBD taken orally in a single dose was found effective in reducing
News and Innovations in Health and Quality of Life